What is kallmann syndrome?
The name ‘Kallmann’ is given after Franz Josef Kallmann, who was the first to describe it as a heritable genetic disorder in 1944, based on his findings in 3 families.1 Kallmann syndrome(KS) is a rare genetic disorder present since birth, where a child is either infertile or has delayed or incomplete puberty.1 Moreover, there is partial or complete loss of smell (anosmia). This is due to the deficiency of gonadotropin-releasing hormone(GnRH), which is responsible for sexual development and maturity. The disease is seen in 1:8000 boys and 1:40000 girls, with underestimated values in women.2
What causes it?
40 types of genes have been associated with this disorder.1 Mutation in genes such as KAL1 FGFR1 or FGF8 can affect the development and migration of gonadotropin-releasing hormone (GnRH) neurons and olfactory nerves (responsible for smelling sensation).1, 2 These GnRH neurons are first seen in the nose region of the fetus and then they migrate to the hypothalamus of the brain during the normal fetus development inside the womb.3
Mutated genes cause a deficiency in GnRH hormones and sex hormones responsible for growth and reproduction. 2
Classic features
- Micropenis (small size) or Cryptorchidism in males and amenorrhoea in females
- Anosmia (loss of smell)
- Lack or delay in puberty
- Hypogonadotropic hypogonadism (lack of hormones that stimulate the ovaries and testes)
Non-reproductive features2
- Hand movements of one side mirror the other side unknowingly, also called bimanual synkinesis, seen in 4.1% to 31% of people4
- Abnormal eye movements,
- Congenital ptosis (drooping of the eyelid since birth)
- Abnormal visual spatial attention( ability to judge how distant the object is)
- Hearing problems
- Agenesis of the corpus callosum(a tissue connecting two halves of the brain) leading to problems of muscle coordination, memory loss and learning difficulties2
- One side(occasionally bilateral) absence of kidneys (26.6% prevalence of kidney anomalies)4
- Cleft lip or palate (a split in the lip and palate of the mouth)
- Failure to form one or several teeth (hypodontia)
- Obesity
| Anomalies | Characteristics | Mechanism | Diagnosis | Clinical implications |
| - Hearing loss and deafness - Prevalence - 5% 5 | - Sensorineural Hearing Loss – most common affects both ears6 - Conductive Hearing Loss – occurs as a result of middle ear problems6 - Mixed Hearing Loss – associated with complex syndromes 6 | - Abnormal development of the inner ear (cochlea) - Gene mutation of CHD7, FGFR1 or SOX10 genes 6 | Audiometry tests | Impacts learning, speech and psychological development |
| Dental anomalies | - Cleft palate or high-arched palate1 - Problems with tooth formation (hypodontia) - Mal-aligned teeth or delayed eruption of teeth - Small teeth, screwdriver-shaped lower incisors teeth and thin roots of molar teeth7 | - Genetic-Gene mutation of FGFR1, and FGF81,7 - Embryologic- The Movement of GnRH neurons in the brain is disturbed | Diagnosed by a dentist and specialist doctors with physical examination and X-rays | Impacts eating, speech, mental health and facial appearance |
Other non-reproductive symptoms
| Anomalies | Features |
| Cranium and face-related | Small jaw, cleft lip and palate, high arch palate and teeth anomalies 1,7 |
| Neurological and Nerve-related | Unknowingly, one hand mirrors the other hand in its movements and4 cognitive imbalance, like difficulty in judgement or language problems |
| Kidney and renal system | One side kidney not formed, unusual location of the kidney, horseshoe-shaped kidney4 |
| Heart | Inborn heart diseases in children, enlarged heart, septal defects 9 |
| Skeleton and bone-related | Short hand and feet, kyphosis in the spine, hand and foot anomalies like fusion of toes and fingers8 |
| Eye | Coloboma, droopy eyelid and squint1 |
Syndromes with overlapping features
Cause - CHD7 gene mutation
Common Features - hypogonadism ( delay in puberty or lack of it), loss of smell and hearing, and squint in the eye 10
Distinguishing features - people with CHARGE syndrome have missing earlobes, defects inside the ears, autism and mental health problems like intellectual disability.10
Cause - SOX10 gene mutation
Common Features - loss of smell, deafness, skin, hair and eye pigmentation, Hirschsprung disease and abnormal hands and legs.11 SOX 10 gene mutation is sometimes seen in Kallmann syndrome.12
Distinguishing feature - Hirschsprung disease is not typically seen in KS.
How to diagnose non-reproductive symptoms?
Diagnosis is largely based on clinical findings.
- Clinical History and Physical Examination - searching in people with KS and their first-degree relatives for tooth anomalies, palate, ear and nose abnormalities and skeletal anomalies like hand and leg deformities1
- Audiological Assessment for loss of hearing1
- Laboratory tests -
- Lower FSH, LH, and thyroid hormone levels are responsible for the delay in growth
- Testosterone <100 ng/dL in males or estradiol <50 pg/mL in females is typical of KS1
- Craniofacial and dental Imaging procedures (head, neck and face imaging) -
- Full mouth X-rays for anomalies of the teeth
- CT scan of the head and neck region to analyse the hypothalamus and pituitary gland1
- Magnetic resonance imaging (MRI) for assessing the development of the olfactory bulbs of the nose and nasal tracts2
- Bone age testing of the hand and wrist using X-rays. People with KS have a delayed bone age1
- Renal Ultrasound - for analysing kidneys and anomalies related to them. Ultrasound of the foetus is done in families with a history of Kallman syndrome2
- Ultrasound to check for shrinking testes
- Genetic Testing - sequencing of genes is done to find mutations and inheritance. People with autosomal dominant inheritance need genetic counseling because they are at a higher risk of transmitting KS to their children1,13
Who does the assessment?
Multiple organs in the body can be affected which is why medical specialists are required for assessment, such as audiologist, ENT, endocrinologist, dentist, geneticist and neurologist.
How to treat this syndrome?
The main aim of the treatment is to gain secondary sexual characteristics, puberty, fertility, bone density and power in the muscles.13
- Hormone replacement therapy - to reverse the effects of hypogonadism (infertility and puberty delay).1 Testosterone (males), and estrogen and progesterone (females) are given to stimulate the development of secondary sexual characteristics, breast development and growth of the penis.2 Studies have shown that gonadotropin injections and hormone replacement therapy both restore fertility by promoting sperm growth and ovulation2
- Hearing aids and ear implants for hearing loss, depending on the intensity
- Speech therapy for treating speech problems caused by tooth loss, high arch palate and cleft lip and palate
- Dental anomalies like malaligned teeth treated by an orthodontist with braces, and cleft lip and palate, need surgical treatment
- Surgery to correct the position of the testicles14
- Monitoring and screening regularly for anomalies in the kidney, spine, hands and legs and neurological changes
- Genetic counselling to prevent transmission to the next generation13
- Providing mental health support and psychiatric counselling to address problems of low self-esteem, learning challenges and psychosexual effects of loss of puberty13
How does it affect the quality of life?
- Both reproductive and nonreproductive symptoms can negatively impact a person's physical and mental development, and their behaviour and attitude towards life. It can also progress to psychosocial issues, which require psychiatric counselling15
- It is important to diagnose it early in life and address the problem promptly
- With comprehensive treatment and care, a person with Kallman syndrome can live a normal and fulfilling life
Recent advances in the diagnosis and treatment of KS
The focus is now on revolutionary and advanced tests to identify new genes and prevent transmission of genetic diseases in the early stages, to the offspring.16
- New generation gene sequencing technologies3 - sequencing of multiple samples of genes in parallel has led to the discovery of newer ones responsible for KS16
- Diagnosis done when the foetus is in the womb (prenatal) can prevent birth defects and transmission of the mutated genes in the next generation16
- Preimplantation genetic testing (PGT) is done in people trying to have children through IVF(test tube babies), to prevent transmission of hereditary disease to the child in early stages16
- Bioinformatic analysis of the genes in olfactory(nose) or GnRH cells is done to identify new factors involved in the disease3
Unsolved questions
- How does KS affect females? What is the prevalence?
- Is the loss of smell without hypogonadism a clinical form of KS?
- What are the genes involved, and how many exactly are responsible for the olfactory and GnRH system interaction
Summary
Although Kallmann syndrome is an uncommon condition, it can have profound negative effects on the person suffering from it as well as their families. Special attention should be paid to early diagnosis through clinical examination and ruling out other possible syndromes. The non-reproductive symptoms are treatable, and a person can live a satisfying life. However, multiple long-term studies are required for understanding the varied and complex role of genes.
FAQS
Is kallmann syndrome reversible?
Studies have shown that in some people, hypogonadism (seen in Kallmann syndrome) is reversed after hormone therapy is withdrawn, called reversible Kallmann syndrome.17
What are the psychological issues associated with it?
Depression, anxiety, low self-esteem and self-contempt are seen in people with Kallmann syndrome, which affect their overall wellbeing and happiness.
Can kallmann syndrome cause reduced life expectancy?
Complications associated with Kallmann syndrome, like osteoporosis, heart problems, cleft lip and palate and infertility, can affect health and overall life span
What are the symptoms of kallmann syndrome seen in females?
Irregular periods, mood swings, loss of smell, missing kidneys and weight gain are some of the symptoms seen in females
References
- Sonne, James, et al. ‘Kallmann Syndrome’. StatPearls, StatPearls Publishing, 2025. PubMed, http://www.ncbi.nlm.nih.gov/books/NBK538210/.
- Dodé, Catherine, and Jean-Pierre Hardelin. ‘Kallmann Syndrome’. European Journal of Human Genetics, vol. 17, no. 2, Feb. 2009, pp. 139–46. www.nature.com, https://doi.org/10.1038/ejhg.2008.206.
- Swee, Du Soon, et al. ‘Recent Advances in Understanding and Managing Kallmann Syndrome’. Faculty Reviews, vol. 10, Apr. 2021, p. 37. PubMed Central, https://doi.org/10.12703/r/10-37.
- Della Valle, Elisa, et al. ‘Prevalence of Olfactory and Other Developmental Anomalies in Patients with Central Hypogonadotropic Hypogonadism’. Frontiers in Endocrinology, vol. 4, June 2013, p. 70. PubMed Central, https://doi.org/10.3389/fendo.2013.00070.
- Salama, Nader. ‘Kallmann Syndrome and Deafness: An Uncommon Combination: A Case Report and a Literature Review’. International Journal of Reproductive Biomedicine, vol. 14, no. 8, Aug. 2016, pp. 541–44. PubMed Central, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015669/.
- Fung, Chak Yuen, et al. ‘Abnormal CT Temporal Bone Findings in a Case of Kallmann Syndrome Presenting with Conductive Hearing Loss’. International Journal of Pediatric Otorhinolaryngology Extra, vol. 8, no. 4, Dec. 2013, pp. 137–39. ScienceDirect, https://doi.org/10.1016/j.pedex.2013.08.005.
- Bailleul‐Forestier, Isabelle, et al. ‘Dental Agenesis in Kallmann Syndrome Individuals with FGFR1 Mutations’. International Journal of Paediatric Dentistry, vol. 20, no. 4, July 2010, pp. 305–12. DOI.org (Crossref), https://doi.org/10.1111/j.1365-263X.2010.01056.x.
- Gannagé-Yared, Marie-Hélène, et al. ‘Coexistence of Kallmann Syndrome and Complete Androgen Insensitivity in the Same Patient’. European Journal of Endocrinology, vol. 152, no. 6, June 2005, pp. 813–17. PubMed, https://doi.org/10.1530/eje.1.01915.
- Moorman, J. Randall, et al. ‘Kallman’s Syndrome with Associated Cardiovascular and Intracranial Anomalies’. The American Journal of Medicine, vol. 77, no. 2, Aug. 1984, pp. 369–72. ScienceDirect, https://doi.org/10.1016/0002-9343(84)90724-1.
- Kim, Hyung-Goo, et al. ‘Mutations in CHD7, Encoding a Chromatin-Remodeling Protein, Cause Idiopathic Hypogonadotropic Hypogonadism and Kallmann Syndrome’. The American Journal of Human Genetics, vol. 83, no. 4, Oct. 2008, pp. 511–19. DOI.org (Crossref), https://doi.org/10.1016/j.ajhg.2008.09.005.
- Rojas, Rebecca A., et al. ‘Phenotypic Continuum between Waardenburg Syndrome and Idiopathic Hypogonadotropic Hypogonadism in Humans with SOX10 Variants’. Genetics in Medicine, vol. 23, no. 4, Apr. 2021, pp. 629–36. DOI.org (Crossref), https://doi.org/10.1038/s41436-020-01051-3.
- Wakabayashi, Tetsuji, et al. ‘A Novel SOX10 Nonsense Mutation in a Patient with Kallmann Syndrome and Waardenburg Syndrome’. Endocrinology, Diabetes & Metabolism Case Reports, vol. 2021, Apr. 2021. DOI.org (Crossref), https://doi.org/10.1530/EDM-20-0145.
- Kumar Yadav, Rajiv, et al. ‘Kallmann Syndrome: Diagnostics and Management’. Clinica Chimica Acta, vol. 565, Jan. 2025, p. 119994. DOI.org (Crossref), https://doi.org/10.1016/j.cca.2024.119994.
- Boehm, Ulrich, et al. ‘European Consensus Statement on Congenital Hypogonadotropic Hypogonadism—Pathogenesis, Diagnosis and Treatment’. Nature Reviews Endocrinology, vol. 11, no. 9, Sept. 2015, pp. 547–64. DOI.org (Crossref), https://doi.org/10.1038/nrendo.2015.112.
- Yoshida, Tomoko, et al. ‘Hypogonadism and Neurocognitive Outcomes among Childhood Cancer Survivors’. European Journal of Endocrinology, vol. 190, no. 3, Mar. 2024, pp. 220–33. DOI.org (Crossref), https://doi.org/10.1093/ejendo/lvae027.
- Liu, Yujun, and Xu Zhi. ‘Advances in Genetic Diagnosis of Kallmann Syndrome and Genetic Interruption’. Reproductive Sciences, vol. 29, no. 6, June 2022, pp. 1697–709. DOI.org (Crossref), https://doi.org/10.1007/s43032-021-00638-8.
- Soumya, Sudarsanababu Lalitha, et al. ‘Reversible Kallmann Syndrome: Rare Yet Real’. Indian Journal of Endocrinology and Metabolism, vol. 23, no. 3, 2019, pp. 382–83. PubMed Central, https://doi.org/10.4103/ijem.IJEM_199_19.

